Also within the IDHmut-codel group, 37 of tumours tested carried TERT C228T or C250T promoter mutations (72%), none of which also carried an ATRX mutation, concordant with the previously reported finding that these are mutually exclusive events2. This evidence concerns the gene ATRX and neoplasm.